Erenumab-Aooe

Common brands: Aimovig, Topamax, Trokendi Xr, Pain Relief, Qudexy Xr

Top reporter: Amgen, Inc

Nonsteroidal Anti-inflammatory Drug [EPC]Acetylcholine Release Inhibitor [EPC]Neuromuscular Blocker [EPC]Corticosteroid [EPC]Tumor Necrosis Factor Blocker [EPC]
53,871
Total Reports
22,473
Serious Reports
2,646
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (4.91%)

Patient Demographics

Male
6,192
Female
37,922

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Erenumab-Aooe.

# Reaction Reports % of Total
1 ACCIDENTAL EXPOSURE TO PRODUCT 10,103
11.2%
2 DEVICE DIFFICULT TO USE 9,916
11.0%
3 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9,479
10.5%
4 DRUG DOSE OMISSION BY DEVICE 6,585
7.3%
5 MIGRAINE 4,943
5.5%
6 DRUG INEFFECTIVE 4,310
4.8%
7 HEADACHE 3,342
3.7%
8 CONSTIPATION 3,179
3.5%
9 PRODUCT STORAGE ERROR 2,974
3.3%
10 INJECTION SITE PAIN 2,848
3.1%
11 OFF LABEL USE 2,706
3.0%
12 NAUSEA 2,374
2.6%
13 FATIGUE 2,232
2.5%
14 ALOPECIA 2,180
2.4%
15 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1,937
2.1%
16 PAIN 1,887
2.1%
17 DIZZINESS 1,819
2.0%
18 ARTHRALGIA 1,584
1.8%
19 MUSCLE SPASMS 1,503
1.7%
20 HYPOAESTHESIA 1,485
1.6%
21 VOMITING 1,459
1.6%
22 RASH 1,417
1.6%
23 WEIGHT INCREASED 1,355
1.5%
24 HYPERTENSION 1,307
1.4%
25 THERAPEUTIC PRODUCT EFFECT DECREASED 1,271
1.4%
26 DEPRESSION 1,270
1.4%
27 DRUG INTOLERANCE 1,266
1.4%
28 PARAESTHESIA 1,256
1.4%
29 DEVICE ISSUE 1,250
1.4%
30 ABDOMINAL PAIN UPPER 1,235
1.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.